Chevy Chase Trust Holdings, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1462020 BETHESDA, MD

Back to REGN Full portfolio

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$159,034,808

+$4,084,222 QoQ

Shares Held

205,833

+2.5% QoQ

Ownership

0.196%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Chevy Chase Trust Holdings, LLC holds $389,793,054 across 7 Biotechnology names. REGN ranks #2 (40.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	407,615	$182,016,401
2	REGN	Regeneron Pharmaceuticals, Inc. This page	205,833	$159,034,808
3	ASND	Ascendis Pharma A/S	123,467	$28,240,606
4	MRNA	Moderna, Inc.	171,318	$8,702,954
5	INCY	Incyte Corp	82,356	$7,751,346
6	TECH	BIO-TECHNE Corp	77,075	$4,027,939
7	CRBU	Caribou Biosciences, Inc.	10,000	$19,000

All Filings in REGN

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$159,034,808	205,833	+2.5%	Shares	Defined	2026-05-15
2025-12-31	$154,950,586	200,747	-1.2%	Shares	Defined	2026-02-13
2025-09-30	$114,226,274	203,152	-1.7%	Shares	Defined	2025-11-14
2025-06-30	$108,532,200	206,728	-6.5%	Shares	Defined	2025-07-29
2025-03-31	$140,298,017	221,210	-3.7%	Shares	Defined	2025-04-23
2024-12-31	$163,669,926	229,767	-3.6%	Shares	Defined	2025-01-30
2024-09-30	$250,593,539	238,379	-1.4%	Shares	Defined	2024-11-14
2024-06-30	$254,090,705	241,754	-0.3%	Shares	Defined	2024-07-22
2024-03-31	$233,288,325	242,380	-2.9%	Shares	Defined	2024-05-03
2023-12-31	$219,200,983	249,577	-0.5%	Shares	Defined	2024-01-24
2023-09-30	$206,497,945	250,921	-0.7%	Shares	Defined	2023-10-23
2023-06-30	$181,598,050	252,732	-0.7%	Shares	Defined	2023-07-25
2023-03-31	$209,088,720	254,468	-1.4%	Shares	Defined	2023-05-17
2022-12-31	$186,241,099	258,134	-7.9%	Shares	Defined	2023-02-09
2022-09-30	$193,120,570	280,344	+5.6%	Shares	Defined	2022-11-04
2022-06-30	$156,923,142	265,463	+6.2%	Shares	Defined	2022-08-10
2022-03-31	$174,629,444	250,035	+7.8%	Shares	Defined	2022-04-27
2021-12-31	$146,433,068	231,874	+4.8%	Shares	Defined	2022-01-31
2021-09-30	$133,899,705	221,256	+22.2%	Shares	Defined	2021-10-20
2021-06-30	$101,092,947	180,995	+6.9%	Shares	Defined	2021-07-20
2021-03-31	$80,120,107	169,337	+23.5%	Shares	Defined	2021-04-22
2020-12-31	$66,248,874	137,130	-3.5%	Shares	Defined	2021-02-12
2020-09-30	$79,513,949	142,045	+6.5%	Shares	Defined	2020-11-06
2020-06-30	$83,183,059	133,381	+56.2%	Shares	Defined	2020-08-14
2020-03-31	$41,701,430	85,403	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.